According to the official WeChat account of China Life Insurance Group, as of the end of August 2024, the total scale of the China Life Health Fund, with a total size of 50 billion yuan, has signed a total of 64 projects, with a total signing amount of approximately 19.4 billion yuan, nurturing 19 listed companies, with a cumulative market cap of nearly 10 trillion yuan. Among the invested companies, technology companies account for over 70%, over 70% of the companies have been recognized as 'national high-tech enterprises', and the proportion of national or provincial-level 'specialized, special and new' enterprises is close to 60%. The internal rate of return of the first phase of the health fund reached 31.69%, with a distribution return multiple of 1.53, far outperforming private equity funds established in the market during the same period.